AI study 'exciting first step' towards improving post-treatment surveillance of lung cancer patients 23 Apr 2022 Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to new research. Find out more Show/Hide
AI test could predict effective cancer drug combinations in less than two days 04 Apr 2022 Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours. Find out more Show/Hide
ICR researchers reveal how they are tackling rare cancers at virtual Discovery Club event 09 Jun 2021 For our latest Discovery Club, members met virtually with some of our leading scientists, who are using cutting-edge methods to assess and treat rare cancers such as sarcoma and other cancers of unmet need. During the evening, guests learned more about how they helping to find new treatment options for these patients who desperately need them - and why philanthropic support is so vital. Find out more Show/Hide